Generated by AI
Organon & Co. is a global pharmaceutical company focused on women’s health, biosimilars, and established prescription medicines. Organon & Co. develops and delivers health solutions across a broad portfolio that includes therapies and medical devices used in reproductive health, contraception, fertility, dermatology, cardiovascular care, respiratory conditions, and other areas of general medicine. The company serves patients and healthcare providers in more than 140 markets through wholesalers, retailers, hospitals, government agencies, and managed care organizations. Its women’s health business is a central part of the portfolio, supported by biosimilars and well-known legacy brands that address everyday treatment needs across multiple therapeutic areas. Organon & Co. operates as a diversified healthcare provider with a strong international footprint and a product mix designed to meet ongoing demand for prescription treatments and essential medicines.
Website30 Hudson Street
Jersey City, NJ, 07302
United States
The latest articles about OGN.
Summary of Jul 4's posts. Generated by AI.
Summary of Apr 29's posts. Generated by AI.
Summary of May 1's posts. Generated by AI.
Investors talking about OGN also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.